(VIANEWS) – Univest Financial Corporation (UVSP), United Therapeutics Corporation (UTHR), H&E Equipment Services (HEES) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Univest Financial Corporation (UVSP)
16.6% sales growth and 10.08% return on equity
Univest Financial Corporation operates as the bank holding company for Univest Bank and Trust Co. that provides banking products and services primarily in Pennsylvania. It operates through three segments: Banking, Wealth Management, and Insurance. The Banking segment provides a range of banking services, such as deposit taking, loan origination and servicing, mortgage banking, other general banking, and equipment lease financing services for individuals, businesses, municipalities, and nonprofit organizations. The Wealth Management segment offers investment advisory, financial planning, and trust and brokerage services for private families and individuals, municipal pension plans, retirement plans, and trusts and guardianships. The Insurance segment provides commercial property and casualty insurance, employee benefits solutions, personal insurance lines, and human resources consulting services. It serves customers primarily in Bucks, Berks, Chester, Cumberland, Dauphin, Delaware, Lancaster, Lehigh, Montgomery, Northampton, Philadelphia, and York counties in Pennsylvania; and Atlantic, Burlington, and Cape May counties in New Jersey through 40 banking offices. The company was formerly known as Univest Corporation of Pennsylvania and changed its name to Univest Financial Corporation in January 2019. Univest Financial Corporation was founded in 1876 and is headquartered in Souderton, Pennsylvania.
Earnings Per Share
As for profitability, Univest Financial Corporation has a trailing twelve months EPS of $2.64.
PE Ratio
Univest Financial Corporation has a trailing twelve months price to earnings ratio of 8.14. Meaning, the purchaser of the share is investing $8.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.08%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 10.3% and 60%, respectively.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 6, 2023, the estimated forward annual dividend rate is 0.84 and the estimated forward annual dividend yield is 3.91%.
2. United Therapeutics Corporation (UTHR)
15.7% sales growth and 16.61% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $15.37.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 15.01. Meaning, the purchaser of the share is investing $15.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.61%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
United Therapeutics Corporation’s EBITDA is 56.82.
Volume
Today’s last reported volume for United Therapeutics Corporation is 342293 which is 37.98% below its average volume of 551929.
Yearly Top and Bottom Value
United Therapeutics Corporation’s stock is valued at $230.76 at 01:22 EST, way below its 52-week high of $283.09 and way above its 52-week low of $173.22.
Previous days news about United Therapeutics Corporation(UTHR)
- According to Zacks on Tuesday, 2 May, "Let’s analyze five drug/biotech companies - United Therapeutics Corporation (UTHR Quick QuoteUTHR – Free Report) , Pacira BioSciences, Inc. (PCRX Quick QuotePCRX – Free Report) , Corcept Therapeutics Incorporated (CORT Quick QuoteCORT – Free Report) , Amarin Corporation plc (AMRN Quick QuoteAMRN – Free Report) and Ionis Pharmaceuticals, Inc. (IONS Quick QuoteIONS – Free Report) - that are set to report first-quarter 2023 results on May 3.", "United Therapeutics Corporation price-consensus-eps-surprise-chart | United Therapeutics Corporation Quote"
3. H&E Equipment Services (HEES)
14.6% sales growth and 37.96% return on equity
H&E Equipment Services, Inc. operates as an integrated equipment services company. The company operates in five segments: Equipment Rentals, Used Equipment Sales, New Equipment Sales, Parts Sales, and Repair and Maintenance Services. The Equipment Rentals segment provides construction and industrial equipment for rent on a daily, weekly, and monthly basis through a fleet of approximately 42,725 pieces of equipment. The Used Equipment Sales segment sells used equipment through retail sales force primarily from its rental fleet, as well as inventoried equipment that are acquired through trade-ins from equipment customers. The New Equipment Sales segment sells new construction equipment through a professional in-house retail sales force. The Parts Sales segment sells parts for the equipment customers, as well as offers for its rental fleet. The Repair and Maintenance Services segment serves its rental fleet and equipment owned customers, as well as offers ongoing preventative maintenance services to industrial customers. It also provides ancillary equipment support activities, including transportation, hauling, parts shipping, and loss damage waivers. The company's rental fleet consists of hi-lift or aerial work platforms, cranes, earthmoving and material handling equipment, and others. It serves industrial and commercial companies, construction contractors, manufacturers, public utilities, municipalities, maintenance contractors, and various other industrial account customers. As of December 31, 2021, the company had a network of 102 service facilities in the Pacific Northwest, West Coast, Intermountain, Southwest, Gulf Coast, Southeast, and Mid-Atlantic regions of the United States. H&E Equipment Services, Inc. was founded in 1961 and is headquartered in Baton Rouge, Louisiana.
Earnings Per Share
As for profitability, H&E Equipment Services has a trailing twelve months EPS of $3.7.
PE Ratio
H&E Equipment Services has a trailing twelve months price to earnings ratio of 11.44. Meaning, the purchaser of the share is investing $11.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.96%.
Sales Growth
H&E Equipment Services’s sales growth is 12.7% for the current quarter and 14.6% for the next.
4. Mid Penn Bancorp (MPB)
12.1% sales growth and 10.94% return on equity
Mid Penn Bancorp, Inc. operates as the bank holding company for Mid Penn Bank that provides commercial banking services to individuals, partnerships, non-profit organizations, and corporations. The company offers various time and demand deposit products, including checking accounts, savings accounts, clubs, money market deposit accounts, certificates of deposit, and IRAs. It also provides a range of loan products comprising mortgage and home equity loans, secured and unsecured commercial and consumer loans, lines of credit, construction financing, farm loans, community development loans, loans to non-profit entities, and local government loans. In addition, the company offers online banking, telephone banking, cash management, and automated teller services, as well as safe deposit boxes; and trust and wealth management services. As of December 31, 2020, it operated thirty-six full service retail banking locations in Berks, Bucks, Chester, Cumberland, Dauphin, Fayette, Lancaster, Luzerne, Montgomery, Northumberland, Schuylkill, and Westmoreland counties, Pennsylvania. The company was founded in 1868 and is headquartered in Millersburg, Pennsylvania.
Earnings Per Share
As for profitability, Mid Penn Bancorp has a trailing twelve months EPS of $3.44.
PE Ratio
Mid Penn Bancorp has a trailing twelve months price to earnings ratio of 6.8. Meaning, the purchaser of the share is investing $6.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.94%.
Sales Growth
Mid Penn Bancorp’s sales growth is 11.2% for the present quarter and 12.1% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 3.42%.
5. Getty Realty Corporation (GTY)
6.7% sales growth and 10.8% return on equity
Getty Realty Corp. is the leading publicly traded real estate investment trust in the United States specializing in the ownership, leasing and financing of convenience store and gasoline station properties. As of September 30, 2020, the Company owned 896 properties and leased 58 properties from third-party landlords in 35 states across the United States and Washington, D.C.
Earnings Per Share
As for profitability, Getty Realty Corporation has a trailing twelve months EPS of $1.77.
PE Ratio
Getty Realty Corporation has a trailing twelve months price to earnings ratio of 18.59. Meaning, the purchaser of the share is investing $18.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.8%.
Yearly Top and Bottom Value
Getty Realty Corporation’s stock is valued at $32.90 at 01:22 EST, under its 52-week high of $36.49 and way higher than its 52-week low of $24.66.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 56.2% and positive 7.4% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 20, 2023, the estimated forward annual dividend rate is 1.72 and the estimated forward annual dividend yield is 5.2%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Getty Realty Corporation’s EBITDA is 13.73.
6. Waters Corporation (WAT)
6.7% sales growth and 162.32% return on equity
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Earnings Per Share
As for profitability, Waters Corporation has a trailing twelve months EPS of $11.66.
PE Ratio
Waters Corporation has a trailing twelve months price to earnings ratio of 25.6. Meaning, the purchaser of the share is investing $25.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 162.32%.
Sales Growth
Waters Corporation’s sales growth is 1% for the present quarter and 6.7% for the next.
Yearly Top and Bottom Value
Waters Corporation’s stock is valued at $298.45 at 01:22 EST, way under its 52-week high of $369.00 and way above its 52-week low of $265.61.
7. Marriot Vacations Worldwide Corporation (VAC)
6.4% sales growth and 14.26% return on equity
Marriott Vacations Worldwide Corporation, a vacation company, develops, markets, sells, and manages vacation ownership and related products. It operates through two segments, Vacation Ownership and Exchange & Third-Party Management. The company manages vacation ownership and related products under the Marriott Vacation Club, Grand Residences by Marriott, Sheraton Vacation Club, Westin Vacation Club, Hyatt Residence Club, and Marriott Vacation Club Pulse brands. It also develops, markets, and sells vacation ownership and related products under The Ritz-Carlton Destination Club brand; and holds right to develop, market, and sell ownership residential products under The Ritz-Carlton Residences brand. As of December 31, 2020, the company operated approximately 100 properties in the United States and 12 other countries and territories. The company sells its upscale tier vacation ownership products primarily through a network of resort-based sales centers and off-site sales locations. Marriott Vacations Worldwide Corporation was founded in 1984 and is headquartered in Orlando, Florida.
Earnings Per Share
As for profitability, Marriot Vacations Worldwide Corporation has a trailing twelve months EPS of $8.84.
PE Ratio
Marriot Vacations Worldwide Corporation has a trailing twelve months price to earnings ratio of 15.54. Meaning, the purchaser of the share is investing $15.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.26%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 3.29B for the twelve trailing months.
Volume
Today’s last reported volume for Marriot Vacations Worldwide Corporation is 293117 which is 19.46% below its average volume of 363952.
